Sartorius Aktiengesellschaft Cash Flow Conversion Efficiency

Latest as of March 2026: 0.049x

Sartorius Aktiengesellschaft cash flow conversion efficiency. Based on the latest financial reports, Sartorius Aktiengesellschaft (SRT) has a cash flow conversion efficiency ratio of 0.049x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€188.90 Million ≈ $220.84 Million USD) by net assets (€3.89 Billion ≈ $4.55 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Sartorius Aktiengesellschaft (2013–2025)

Cash flow conversion efficiency of Sartorius Aktiengesellschaft from 2013 to 2025. This chart illustrates how Sartorius Aktiengesellschaft's cash flow conversion efficiency has evolved over time, based on yearly financial data. View current stock price of Sartorius Aktiengesellschaft for real-time trading data and today's change.

Sartorius Aktiengesellschaft Cash Flow Conversion Ratio Explained

Sartorius Aktiengesellschaft cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Sartorius Aktiengesellschaft Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Sartorius Aktiengesellschaft ranked by their cash flow conversion efficiency. Also see SRT market cap overview for the company's overall valuation and market capitalisation.

Company Cash Flow Conversion Efficiency
Zhaojin Mining Industry Company Limited
F:ZVL
-0.011x
Sanlam Ltd
JSE:SLM
0.114x
Zhengzhou Yutong Bus Co Ltd
SHG:600066
0.006x
Raytron Technology Co Ltd
SHG:688002
0.057x
Futu Holdings Ltd
NASDAQ:FUTU
0.031x
SKANSKA AB (SPONS.ADR)/1
F:SKN
0.121x
WISETECH GLOBAL USP.ADRS
F:17W0
N/A
Qantas Airways Ltd
AU:QAN
1.251x

Annual Cash Flow Conversion Efficiency for Sartorius Aktiengesellschaft (2013–2025)

The table below shows the annual cash flow conversion efficiency of Sartorius Aktiengesellschaft from 2013 to 2025. Review free cash flow generation of Sartorius Aktiengesellschaft to assess how much free cash flow the company generates relative to operating cash flow.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 €3.87 Billion
≈ $4.52 Billion
€837.00 Million
≈ $978.54 Million
0.216x -13.58%
2024-12-31 €3.90 Billion
≈ $4.56 Billion
€976.20 Million
≈ $1.14 Billion
0.250x -15.90%
2023-12-31 €2.76 Billion
≈ $3.22 Billion
€821.30 Million
≈ $960.19 Million
0.298x +7.84%
2022-12-31 €2.66 Billion
≈ $3.11 Billion
€734.20 Million
≈ $858.36 Million
0.276x -45.60%
2021-12-31 €1.72 Billion
≈ $2.01 Billion
€873.20 Million
≈ $1.02 Billion
0.508x +39.15%
2020-12-31 €1.40 Billion
≈ $1.64 Billion
€511.52 Million
≈ $598.03 Million
0.365x +4.57%
2019-12-31 €1.08 Billion
≈ $1.26 Billion
€377.19 Million
≈ $440.97 Million
0.349x +38.87%
2018-12-31 €973.39 Million
≈ $1.14 Billion
€244.52 Million
≈ $285.87 Million
0.251x -1.89%
2017-12-31 €806.56 Million
≈ $942.95 Million
€206.51 Million
≈ $241.43 Million
0.256x +10.70%
2016-12-31 €736.80 Million
≈ $861.40 Million
€170.42 Million
≈ $199.24 Million
0.231x +18.96%
2015-12-31 €644.75 Million
≈ $753.78 Million
€125.36 Million
≈ $146.56 Million
0.194x -25.39%
2014-12-31 €497.66 Million
≈ $581.82 Million
€129.69 Million
≈ $151.62 Million
0.261x +13.63%
2013-12-31 €450.25 Million
≈ $526.39 Million
€103.26 Million
≈ $120.72 Million
0.229x --

About Sartorius Aktiengesellschaft

F:SRT Germany Medical Instruments & Supplies
Market Cap
$9.43 Billion
€8.06 Billion EUR
Market Cap Rank
#2262 Global
#477 in Germany
Share Price
€235.50
Change (1 day)
+2.61%
52-Week Range
€161.00 - €235.50
All Time High
€829.87
About

Sartorius Aktiengesellschaft provides bioprocess solutions, and lab products and services worldwide. The company offers analytical solutions, such as biolayer interferometry systems, high-throughput screening by cytometry systems, process analytical technology and data analytics, cell selection and retrieval, live-cell imaging and analysis systems, and surface plasmon resonance systems; cell cult… Read more